endometrial cancer
Conditions
Interventions
Interventinal group:Sentinel lymph node detection
Control group:lymph node dissection
Interventinal group:chemoradiotherapy
Control group:chemotherapy
Sponsors
Shanghai First Maternity and Infant Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Female, aged >= 18 years and <= 75 years old (calculated on the day of signing the informed consent); 2. Histologically confirmed endometrioid, serous and clear cell carcinoma; 3. There are enough tissue specimens for molecular typing testing; 4. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. Any other malignant tumors within 5 years 2. According to the judgment of the investigator, the participant has other factors that may cause the study to be terminated midway. 3. During pregnancy or lactating. 4. There are not enough tissue specimens for molecular typing testing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression-free survival, PFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival, OS; | — |
Countries
China
Contacts
Public ContactWan Xiaoping
Shanghai First Maternity and Infant Hospital
Outcome results
None listed